Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2883
Revised: April 6, 2004
Accepted: April 13, 2004
Published online: October 1, 2004
AIM: To quantify the inhibition of HBV replication by targeted ribonuclease by using real-time fluorescent PCR.
METHODS: Targeted ribonuclease was introduced into 2.2.15 cells by liposome-mediated transfection or HIV-TAT mediated protein transduction. Forty-eight hours after the transfection and 24 h after the transduction, supernatants of 2.2.15 cells were collected and HBV DNA in the supernatants was quantified by real-time fluorescent PCR with a commercial kit.
RESULTS: HBV DNA concentrations in the supernatants of 2.2.15 cells transfected or transducted with targeted ribonuclease were 4.9 ± 2.4 × 108 copies/L and 8.3 ± 4.0 × 108 copies/L, respectively. Compared with controls, transfection or transduction of targeted ribonuclease reduced HBV DNA concentration in the supernatants of 2.2.15 cells by 90.4% and 90.1%, respectively (P < 0.05).
CONCLUSION: Targeted ribonuclease can inhibit HBV replication in 2.2.15 cells.